We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Grassley Invites HHS IG to Testify on EpiPen’s CMS Misclassification
Grassley Invites HHS IG to Testify on EpiPen’s CMS Misclassification
Sen. Chuck Grassley (R-Iowa) is continuing his investigation into Mylan’s ballooning pricing of the EpiPen and government rebates that it has received, requesting more information in the latest of a series of letters to manufacturer and several federal agencies.